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Table 1: CMR data according to the presence of fQRS. N(%) or median
(25th-75th). 
Conclusions: These findings give further support to the argument that
fQRS is a reliable marker of infarct size and could explain its strong prog-
nostic value after AMI.
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Background. We investigated the relationships between the autonomic
nervous system, as assessed by heart rate variability (HRV) and levels of N-
terminal Pro-B-type Natriuretic Peptide (Nt-proBNP), in the setting of acute
myocardial infarction (MI).
Patients and method. Plasma Nt-proBNP (Elecsys, Roche) was measured
on admission in patients admitted < 24h for acute MI. Patients with chronic
atrial fibrillation or pace maker were excluded. The mean of standard devia-
tion of RR intervals (SDNN), percentage of RR intervals with >50ms variation
(pNN50), square root of mean squared differences of successive RR intervals
(rMSSD), and frequency domain parameters (total power (TP), high frequency
and low frequency power ratio (LF/HF)) were assessed by 24h holter ECG
monitoring at 5 ± 2 days after MI onset.
Results. Among the 1018 patients included, median (IQR) Nt-proBNP
value was 681(159-2432) pmol/L. Patients with highest quartile of Nt-proBNP
were older, were more likely to be women, hypertensive, had higher admis-
sion heart rate, lower LVEF, but were less likely to be smokers. Highest Nt-
proBNP quartile group had lower SDNN, LF/HF and total power but similar
pNN50 and rMSSD levels. Nt-proBNP levels was negatively associated with
TP (r=–0.17, p<0.001), SDNN (r=–0.19, p<0.001), LF/HF (r=–0.37, p<0.001),
and LF (r=–0.29, p<0.001) but not HF (r=–0.043, p=0.172). Multiple regres-
sion analysis showed that plasma propeptide level remains predictive of LF/
HF (B(SE)=–0.065(0.015), p<0.001)), after adjustment for confounding (Beta-
blockers, female, and age). 
Conclusions: Our population-based study suggests the importance of Nt-
proBNP levels to predict decreased HRV after acute MI. Moreover, our results
highlight that high Nt-proBNP levels are associated with a decrease in the
effects of the sympathetic system. Further experimental studies are needed to
explore the impact of such findings.
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Context: Periodontal disease, including bone loss, increases the risk of ath-
erosclerosis through plaque destabilization. Multiple complex coronary lesions
(MCL), defined by stenosis >50%, and at least two of the following: chronic
occlusion, impaired flow, thrombus , irregularity, and ulceration of the lesion,
are associated with multifocal destabilization of atherosclerotic coronary
plaque. We investigated whether significant bone loss could predict the pres-
ence of MCL.
Materials and methods: 150 consecutive patients who initiated outpatient
cardiac rehabilitation between 2007 and 2010 for myocardial infarction <1
month and who underwent coronary angiography were included. Patients
without or simple complex coronary lesions (SCL group) were compared to
patients with MCL. A panoramic dental x-ray was made including bone loss>
50%. 
Results: Over 20% of patients had MCL (32/150), and patients in the SCL and
MCL groups had similar cardiovascular risk factors. However, patients with MCL
were less likely to be women and more likely to have multivessel disease than
were patients in the SCL group (21% vs. 6%, p=0.051, and 88% vs. 46%,
p<0.001). Bone loss> 50% tended to be more frequent in patients with MCL than
in those with SCL (50% vs. 32%, p=0.063). In addition, patients with MCL had a
higher CRP level (CRP> 10 mg/L: 15% vs. 42% p=0.001). In multivariate anal-
ysis, multivessel disease (OR (95% CI): 6.63 (2.09-21.03), and CRP>10 mg/L
(OR (95% CI): 3.98 (1.48-10.69)) were associated with the presence of MCL.
Female sex (OR (95% CI): 0.23 (0.04-1.22) tended to be associated with SCL. In
addition, bone loss> 50% significantly increased the risk of MCL (OR 2.63 (1.03-
6.71) p=0.043)) even after adjustment for other predictors of MCL. 
Conclusion: Bone loss, a simple parameter of periodontal evaluation, cor-
related with complex and multiple coronary lesions, independently of other
known factors associated with MCL, including systemic inflammation.
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Aim: Assess if invasive coronary angiogram (CA) can be replaced by mul-
tislice coronary tomography (MSCT) (64 – /256-row) for the systematic rule
out of coronary vasculopathy in heart transplant patients.
Methods: Electrocardiogram-gated contrast-enhanced MSCT (Philipps, Bril-
liance, 64-row for the first 25 patients and 256-row for the others) was per-
formed 24 hours before annual CA. MSCT parameters, adapted to the patient’s
weight, include 120 kV, 800mAs, 0.625 mm slice thickness, 0.42s/0.27s rotation
time. Coronary segments > 1.5 mm were classified as stenosis (stenosis>50%),
atheroma (stenosis<50%) or normal and blindly compared to CA.
The primary endpoint was the negative predictive value (NPV) of MSCT for
the detection of significant (stenosis>50%) coronary artery disease (CAD). Sec-
ondary endpoints were the comparison of X-Ray (mSv) and iodine contrast agent
(ml) exposures. We plan to present the final results (n=102) at SFC meeting.
Results: 87 patients were prospectively included. Mean age was 52 ± 13 years.
Heart transplantation occurred 6±5 years before inclusion. 1108 (97.8%) segments
No fQRS 
n=118 (n=739)
fQRS 
n=128 
p
LVEF, % 56 (48-62) 49 (39-58) <0.001
EDV index (mL/m2) 135 (105-170) 155 (129-190) <0.001
ESV index (mL/m2) 60 (47-77) 76 (57-104) <0.001
Presence of PMO, n (%) 46 (39) 73 (57) 0.007
Presence of MO, n (%) 71(60) 93 (72) 0.052
Extent of PMO, (%) 1.98 (0.95-4.2) 3.5 (1.7-5.6) 0.018
Extent of MO, (%) 8.55 (3.9-14.7) 12.7 (6-23) 0.022
IS, (%) 16 (9-25) 25 (15-34) <0.001
